116 related articles for article (PubMed ID: 21214675)
1. Decrease of hepatic stellate cells in rats with enhanced sensitivity to clofibrate-induced hepatocarcinogenesis.
Yamana D; Shimizu T; Fan Y; Miura T; Nanashima N; Yamada T; Hakamada K; Tsuchida S
Cancer Sci; 2011 Apr; 102(4):735-41. PubMed ID: 21214675
[TBL] [Abstract][Full Text] [Related]
2. Different susceptibility to peroxisome proliferator-induced hepatocarcinogenesis in rats with polymorphic glutathione transferase genes.
Kudo T; Asano J; Shimizu T; Nanashima N; Fan Y; Akita M; Ookawa K; Hayakari M; Yokoyama Y; Suto K; Tsuchida S
Cancer Sci; 2006 Aug; 97(8):703-9. PubMed ID: 16800819
[TBL] [Abstract][Full Text] [Related]
3. Histone acetylation and steroid receptor coactivator expression during clofibrate-induced rat hepatocarcinogenesis.
Asano J; Kudo T; Shimizu T; Fan Y; Nanashima N; Yamana D; Miura T; Yamada T; Tsuchida S
Cancer Sci; 2010 Apr; 101(4):869-75. PubMed ID: 20132223
[TBL] [Abstract][Full Text] [Related]
4. Lack of peroxisomal enzyme inducibility in rat hepatic preneoplastic lesions induced by mutagenic carcinogens: contrasted expression of glutathione S-transferase P form and enoyl CoA hydratase.
Yokoyama Y; Tsuchida S; Hatayama I; Sato K
Carcinogenesis; 1993 Mar; 14(3):393-8. PubMed ID: 8453714
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of glutathione S-transferases and increased fatty change in peroxisomal enzyme-negative foci induced by clofibrate in rat livers.
Nishimura S; Yokoyama Y; Nakano H; Satoh K; Kano H; Sato K; Tsuchida S
Carcinogenesis; 1995 Aug; 16(8):1699-704. PubMed ID: 7634392
[TBL] [Abstract][Full Text] [Related]
6. Glutathione S-transferase A4 is a positive marker for rat hepatic foci induced by clofibrate and genotoxic carcinogens.
Shimizu T; Fan Y; Yamana D; Miura T; Nanashima N; Yamada T; Tsuchida S
Cancer Sci; 2010 May; 101(5):1093-8. PubMed ID: 20180811
[TBL] [Abstract][Full Text] [Related]
7. The relationship between decrease in Cx32 and induction of P450 isozymes in the early phase of clofibrate hepatocarcinogenesis in the rat.
Shoda T; Mitsumori K; Onodera H; Toyoda K; Uneyama C; Imazawa T; Hirose M
Arch Toxicol; 1999 Sep; 73(7):373-80. PubMed ID: 10550479
[TBL] [Abstract][Full Text] [Related]
8. Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells.
Chong LW; Hsu YC; Lee TF; Lin Y; Chiu YT; Yang KC; Wu JC; Huang YT
BMC Gastroenterol; 2015 Feb; 15():22. PubMed ID: 25886887
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of GADD45 genes during the development of chemical-mediated liver hypertrophy and liver tumor promotion in rats.
Ozawa S; Gamou T; Habano W; Inoue K; Yoshida M; Nishikawa A; Nemoto K; Degawa M
J Toxicol Sci; 2011 Oct; 36(5):613-23. PubMed ID: 22008536
[TBL] [Abstract][Full Text] [Related]
10. Cooperation of liver cells in health and disease.
Kmieć Z
Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling and functional assays of activated hepatic stellate cells suggest that myocardin has a role in activation.
Shimada H; Ochi T; Imasato A; Morizane Y; Hori M; Ozaki H; Shinjo K
Liver Int; 2010 Jan; 30(1):42-54. PubMed ID: 19793196
[TBL] [Abstract][Full Text] [Related]
12. Modulation of diethylnitrosamine-initiated placental glutathione S-transferase positive preneoplastic and neoplastic lesions by clofibrate, a hepatic peroxisome proliferator.
Hosokawa S; Tatematsu M; Aoki T; Nakanowatari J; Igarashi T; Ito N
Carcinogenesis; 1989 Dec; 10(12):2237-41. PubMed ID: 2686852
[TBL] [Abstract][Full Text] [Related]
13. Mistletoe alkaloid fractions alleviates carbon tetrachloride-induced liver fibrosis through inhibition of hepatic stellate cell activation via TGF-β/Smad interference.
Jiang Y; Wang C; Li YY; Wang XC; An JD; Wang YJ; Wang XJ
J Ethnopharmacol; 2014 Dec; 158 Pt A():230-8. PubMed ID: 25456431
[TBL] [Abstract][Full Text] [Related]
14. Decreased connexin32 and a characteristic enzyme phenotype in clofibrate-induced preneoplastic lesions not shared with spontaneously occurring lesions in the rat liver.
Tsuda H; Asamoto M; Iwahori Y; Hori T; Ota T; Baba-Toriyama H; Uehara N; Kim DJ; Krutovskikh VA; Takasuka N; Tsuchiya T; Mutai M; Tatematsu M; Yamasaki H
Carcinogenesis; 1996 Nov; 17(11):2441-8. PubMed ID: 8968061
[TBL] [Abstract][Full Text] [Related]
15. alpha(2)-Macroglobulin: a novel cytochemical marker characterizing preneoplastic and neoplastic rat liver lesions negative for hitherto established cytochemical markers.
Sukata T; Uwagawa S; Ozaki K; Sumida K; Kikuchi K; Kushida M; Saito K; Morimura K; Oeda K; Okuno Y; Mikami N; Fukushima S
Am J Pathol; 2004 Nov; 165(5):1479-88. PubMed ID: 15509519
[TBL] [Abstract][Full Text] [Related]
16. Macrophage and hepatic stellate cell responses during experimental hepatocarcinogenesis.
Johnson SJ; Burr AW; Toole K; Dack CL; Mathew J; Burt AD
J Gastroenterol Hepatol; 1998 Feb; 13(2):145-51. PubMed ID: 10221815
[TBL] [Abstract][Full Text] [Related]
17. The Salvia miltiorrhiza monomer IH764-3 induces apoptosis of hepatic stellate cells in vivo in a bile duct ligation-induced model of liver fibrosis.
Liu L; Wei J; Huo X; Fang S; Yao D; Gao J; Jiang H; Zhang X
Mol Med Rep; 2012 Dec; 6(6):1231-8. PubMed ID: 22971838
[TBL] [Abstract][Full Text] [Related]
18. Loss of peroxisomal enzyme expression in preneoplastic and neoplastic lesions induced by peroxisome proliferators in rat livers.
Yokoyama Y; Tsuchida S; Hatayama I; Satoh K; Narita T; Rao MS; Reddy JK; Yamada J; Suga T; Sato K
Carcinogenesis; 1992 Feb; 13(2):265-9. PubMed ID: 1740018
[TBL] [Abstract][Full Text] [Related]
19. Clofibrate-induced neoplastic development in the rat liver is associated with decreased connexin 32 expression but not with a co-ordinated shift in expression of marker enzymes.
Tsuda H; Asamoto M; Baba-Toriyama H; Iwahori Y; Hori T; Kim DJ; Tsuchiya T; Mutai M; Yamasaki H
Toxicol Lett; 1995 Dec; 82-83():693-9. PubMed ID: 8597128
[TBL] [Abstract][Full Text] [Related]
20. Anti-fibrotic activity and enhanced interleukin-6 production by hepatic stellate cells in response to imatinib mesylate.
Kim Y; Fiel MI; Albanis E; Chou HI; Zhang W; Khitrov G; Friedman SL
Liver Int; 2012 Jul; 32(6):1008-17. PubMed ID: 22507133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
